|
||
| |||||||
|
|
MILFORD, MA (November 3, 2006) — Thermo Electron Corporation, the world leader in analytical instruments, has entered into a collaborative research and development agreement with the Research in Immune Tolerance in Transplantation (RITT) program. The research will be conducted in the RITT Industrial BioDevelopment Laboratory at the Toronto General Hospital. As part of this collaboration, the state-of-the-art RITT Industrial BioDevelopment Laboratory (IBDL) has been equipped with over $1,000,000 (Canadian) of Thermo laboratory equipment, making this one of the IBDL’s biggest investments in a single supplier. The RITT program is a new $10 million initiative that aims to fully understand the biology of transplant rejection in order to develop treatments to prevent it. The program is part of the research arm of the Multi Organ Transplant Program - one of North America’s largest transplant programs. As well as equipping the IBDL with biological safety cabinets, incubators, freezers, microplate instrumentation, a KingFisher magnetic particle processor, and a liquid chromatography and mass spectrometry system (LC/MS), Thermo will also support the RITT program’s objectives by funding a post-doctoral research scientist for two years. The ‘Thermo Electron Corporation Bioanalytical Post-doctoral Fellow’ will work on projects of joint interest to the RITT program and Thermo in the areas of assay development and biomolecule purification using the latest Thermo instrumentation. Additionally, Thermo will provide training workshops in its many areas of expertise. Dr. Gary Levy, the director of the Multi Organ Transplant Program and the RITT program, and an internationally-renowned expert in organ transplantation stated, “This partnership with a world leader in scientific instrumentation such as Thermo is an exciting step forward. This new collaborative environment between industry and academia is key to successfully translating medical research from the bench to the bedside.” “Our collaboration with the RITT program demonstrates our ability to provide customers with total laboratory solutions,” said Marc N. Casper, senior vice president of Thermo Electron Corporation. “In turn, customers can spend less time managing their lab and instead focus on their promise of their research. We look forward to great things to come from RITT.” The RITT program’s new Industrial BioDevelopment Laboratory is a brand new facility with a mandate to bridge the gap between academia and industry and accelerate the commercialization of new technology. It has been funded jointly by the Canadian federal government (Canada Foundation for Innovation), the province of Ontario (Ontario Research Foundation), and the Toronto General Hospital. # # # About Thermo Electron Corporation Thermo Electron Corporation is the world leader in analytical instruments. Our instrument solutions enable our customers to make the world a healthier, cleaner and safer place. Thermo's Life and Laboratory Sciences segment provides analytical instruments, scientific equipment, services and software solutions for life science, drug discovery, clinical, environmental and industrial laboratories. Thermo's Measurement and Control segment is dedicated to providing analytical instruments used in a variety of manufacturing processes and in-the-field applications, including those associated with safety and homeland security. For more information, visit http://www.thermo.com . Media Contact Information David Robinson Andrew Dunn Alto Marketing Ltd Thermo Electron Corporation Phone: +44 (0)1489 557672 Phone: +1 828-365-1205 E-mail: davidr@alto-marketing.com E-mail: andrew.dunn@thermo.com |
|
| ||||||||
